Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Placing to raise ?1.0m

3 Dec 2009 07:00

RNS Number : 5057D
Ultima Networks PLC
03 December 2009
 



For immediate release 3 December 2009

Ultima Networks plc

("Ultima" or the "Company")

Placing to raise £1.0 million (the "Placing")

Ultima, the AIM listed green technology company, announces that it has conditionally raised £1.0 million (before expenses) through a placing arranged by the Company's nominated adviser, Allenby Capital Limited, of 71,428,574 new ordinary shares in the Company (the "Placing Shares") at a price of 1.4 pence per ordinary share (the "Placing Price")The Placing Shares will represent 25.86% of the Company's enlarged issued ordinary share capital.

The net proceeds of the Placing will be used by the Company for the development of its solar park operations in Italy. Specifically, the funds will be put towards the construction and commissioning of an initial 1MW solar park in the Puglia region of Southern Italy, which is being developed by the Company's Green Power division. As well as the Placing funds, Ultima intends to put in place debt financing of c.£3.0 million to facilitate the construction of this 1MW solar park. The Company is in early stage discussions with potential debt funders in Italy to provide such funding although at this stage there is no guarantee that such debt funding will be provided or as to the terms of such debt funding.

As announced in November 2008 the Company owns 22 hectares of land in the Puglia region of Southern Italy on which it is developing solar power generation capacity. The Company has planning permission and authorisations to build a total of three 1MW solar parks in this region and the acquired land has sufficient space for a further two 1MWs for which authorisation applications are in progress

As part of the Placing, Professor Humayun Mughal (Chairman and Chief Executive Officer of the Company) has subscribed for 5,357,143 Placing Shares at the Placing Price and Yasmin Mughal (wife of Humayan Mughal) has subscribed for 1,071,429 Placing Shares at the Placing Price. Following completion of the Placing Professor Humayun Mughal and his connected parties will be interested in 109,789,462 ordinary shares in the Company representing 39.75of the enlarged issued ordinary share capital.

In addition, as part of the Placing, Allenby Capital Limited have subscribed for 8,214,286 Placing Shares, at the Placing Price, representing 2.97% of the enlarged issued ordinary share capital. The Company has also issued Allenby Capital Limited with warrants to subscribe for 2,761,765 new ordinary shares of 1p each in the Company. The exercise price is 1.4 pence per ordinary share and the warrants are exercisable at any time within five years from Admission (as defined below).

Application will be made for the Placing Shares (which when issued and fully paid will rank pari passu in all respects with the existing ordinary shares) to be admitted to trading on AIM ("Admission") and Admission is expected to be effective on 8 December 2009. Following Admission, the Company will have 276,176,538 ordinary shares in issue.

Professor Humayun Mughal, Chairman and Chief Executive Officer of Ultima, said:

"I am delighted with the support that we have received in this equity fundraising, which will enable us to commence development of our solar activities in Southern Italy. I look forward to making further announcements on this exciting development in due course."

For further information, please contact:

Ultima Networks plc Tel: 01279 821 200 Humayun Mughal, Chairman and Chief Executive Officer

Allenby Capital Limited (nominated adviser) Tel: 0203 328 5656   Nick Naylor  Nick Athanas

Jamie Boyd

Threadneedle Communications Tel: 0207 653 9850 Graham Herring Alex White

About Ultima Networks Plc

Ultima operates three divisions:

Green Power - involved in the development of solar power parks in Italy and Spain

Green Technology - responsible for the design, development and distribution of electric bicycles and other green technology products

 IT and related services - develops and supplies computer-based application software and services to the legal profession

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUUVWRKWRURAA
Date   Source Headline
17th Mar 202612:14 pmRNSResult of General Meeting and Change of Name
27th Feb 20267:00 amRNSNotice of GM and Proposed Change of Name
24th Feb 20267:00 amRNSCEO Appointment & Name Change Thalia Therapeutics
17th Dec 20257:00 amRNSBusiness and Operational Update
25th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSPartnership with University of Strathclyde’s CMAC
22nd Sep 20257:00 amRNSN4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
11th Sep 20257:00 amRNS-RInvestor Event and Presentation
30th Jul 20251:55 pmRNS-RArticle on Nuvec®’s Potential in RNA Therapeutics
14th Jul 20257:00 amRNS-RInvestor Webinar
8th Jul 20257:00 amRNSDirectorate Change
30th Jun 20252:15 pmRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
25th Jun 20257:00 amRNS-RInsight Event for Retail Investors
6th Jun 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
27th May 20257:00 amRNS-REstablishment of New Senior Leadership Team
23rd May 202512:37 pmRNSTR-1: Notification of major holdings
21st May 20254:11 pmRNSHolding(s) in Company
15th May 20253:13 pmRNSChange of Registered Address
12th May 20257:00 amRNSN4 101 In Vivo Study Results
9th May 20258:24 amRNSHolding(s) in Company
29th Apr 20254:25 pmRNSHolding(s) in Company
29th Apr 202511:05 amRNSHolding(s) in Company
28th Apr 20252:30 pmRNSHolding(s) in Company
23rd Apr 20252:32 pmRNSTR-1: Standard form notification of major holdings
22nd Apr 202511:56 amRNSResult of General Meeting
4th Apr 20257:08 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20254:08 pmRNSPlacing and Subscription to raise £1,750,000
18th Feb 202512:34 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNS-RInvestor Webinar
27th Jan 20257:00 amRNS-RInvestor Webinar
16th Jan 20257:00 amRNS-RN4 Pharma Non-Executive Director Q&A
8th Jan 20257:00 amRNSDirectorate Changes
12th Dec 20247:00 amRNSN4 101 In Vitro Results
4th Dec 20247:00 amRNSNew Patent Filing
28th Nov 20247:00 amRNSGrant of Options
24th Sep 20247:00 amRNSInterim Results
17th Sep 20248:04 amRNSSRI Research Update
9th Sep 20247:00 amRNSDirector Appointment
23rd Aug 20248:30 amRNSChange of Auditor
20th Aug 20247:00 amRNSSRI Research Update
3rd Jul 20247:00 amRNSNanogenics Update
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.